Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Honigberg, B.M.
and
Burgess, Donald E.
1994.
Parasitic Protozoa.
p.
1.
North, Michael J.
1994.
Proteolytic Enzymes: Serine and Cysteine Peptidases.
Vol. 244,
Issue. ,
p.
523.
Provenzano, D
and
Alderete, J F
1995.
Analysis of human immunoglobulin-degrading cysteine proteinases of Trichomonas vaginalis.
Infection and Immunity,
Vol. 63,
Issue. 9,
p.
3388.
Robertson, Colin D.
Coombs, Graham H.
North, Michael J.
and
Mottram, Jeremy C.
1996.
Parasite cysteine proteinases.
Perspectives in Drug Discovery and Design,
Vol. 6,
Issue. 1,
p.
99.
Alderete, J F
and
Provenzano, D
1997.
The vagina has reducing environment sufficient for activation of Trichomonas vaginalis cysteine proteinases..
Sexually Transmitted Infections,
Vol. 73,
Issue. 4,
p.
291.
Min, D Y
Hyun, K H
Ryu, J S
Ahn, M H
and
Cho, M H
1998.
Degradations of human immunoglobulins and hemoglobin by a 60 kDa cysteine proteinase of Trichomonas vaginalis.
The Korean Journal of Parasitology,
Vol. 36,
Issue. 4,
p.
261.
Patel, Sangnya R.
Wiese, Wilhelmine
Patel, Sanjay C.
Ohl, Christopher
Byrd, James C.
and
Estrada, Carlos A.
2000.
Systematic review of diagnostic tests for vaginal trichomoniasis.
Infectious Diseases in Obstetrics and Gynecology,
Vol. 8,
Issue. 5-6,
p.
248.
Sutcliffe, Siobhan
Giovannucci, Edward
Alderete, John F.
Chang, Te-Hung
Gaydos, Charlotte A.
Zenilman, Jonathan M.
De Marzo, Angelo M.
Willett, Walter C.
and
Platz, Elizabeth A.
2006.
Plasma Antibodies against Trichomonas vaginalis and Subsequent Risk of Prostate Cancer.
Cancer Epidemiology, Biomarkers & Prevention,
Vol. 15,
Issue. 5,
p.
939.
Kummer, Shelley
Hayes, Gary R.
Gilbert, Robert O.
Beach, David H.
Lucas, John J.
and
Singh, Bibhuti N.
2008.
Induction of human host cell apoptosis by Trichomonas vaginalis cysteine proteases is modulated by parasite exposure to iron.
Microbial Pathogenesis,
Vol. 44,
Issue. 3,
p.
197.
Ramón‐Luing, Lucero A.
Rendón‐Gandarilla, Francisco J.
Cárdenas‐Guerra, Rosa E.
Rodríguez‐Cabrera, Norma A.
Ortega‐López, Jaime
Avila‐González, Leticia
Angel‐Ortiz, Claudia
Herrera‐Sánchez, Carmen N.
Mendoza‐García, Manuela
and
Arroyo, Rossana
2010.
Immunoproteomics of the active degradome to identify biomarkers for Trichomonas vaginalis.
PROTEOMICS,
Vol. 10,
Issue. 3,
p.
435.
Burgess, Donald E.
2010.
Topley & Wilson's Microbiology and Microbial Infections.
Huang, Kuo-Yang
Huang, Po-Jung
Ku, Fu-Man
Lin, Rose
Alderete, John F.
Tang, Petrus
and
Urban, J. F.
2012.
Comparative Transcriptomic and Proteomic Analyses of Trichomonas vaginalis following Adherence to Fibronectin.
Infection and Immunity,
Vol. 80,
Issue. 11,
p.
3900.
Volpedo, Greta
Huston, Ryan H
Holcomb, Erin A
Pacheco-Fernandez, Thalia
Gannavaram, Sreenivas
Bhattacharya, Parna
Nakhasi, Hira L
and
Satoskar, Abhay R
2021.
From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection.
Expert Review of Vaccines,
Vol. 20,
Issue. 11,
p.
1431.
Alderete, John F.
and
Chan, Hermes
2023.
Point-of-Care Diagnostic for Trichomonas vaginalis, the Most Prevalent, Non-Viral Sexually Transmitted Infection.
Pathogens,
Vol. 12,
Issue. 1,
p.
77.
Euceda-Padilla, Esly Alejandra
Mateo-Cruz, Miriam Guadalupe
Ávila-González, Leticia
Flores-Pucheta, Claudia Ivonne
Ortega-López, Jaime
Talamás-Lara, Daniel
Velazquez-Valassi, Beatriz
Jasso-Villazul, Lidia
and
Arroyo, Rossana
2024.
Trichomonas vaginalis Legumain-2, TvLEGU-2, Is an Immunogenic Cysteine Peptidase Expressed during Trichomonal Infection.
Pathogens,
Vol. 13,
Issue. 2,
p.
119.